Search

Your search keyword '"Raúl Menor Almagro"' showing total 8 results
Start Over Author "Raúl Menor Almagro" Search Limiters Peer Reviewed
8 results on '"Raúl Menor Almagro"'

1. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

Author

Jesús Tornero, Alba Erra, Santos Castañeda, Carolina Pérez-García, Raimon Sanmartí, Sara Marsal, Ingrid Moller, Esperanza Naredo, Miguel A González-Gay, Celia Erausquin, Ivan Castellví, Javier Llorca, Alejandro Muñoz, María Galindo, Enrique Raya, Lydia Abasolo, Gema Bonilla, Alfonso Corrales, Inmaculada Ureña, Carlos Rodríguez-Lozano, Carlos González-Juanatey, Cristina Fernandez Carballido, Francisco J López-Longo, Miguel Ángel González-Gay, Eduardo Collantes, José A Miranda-Filloy, Sagrario Bustabad, Indalecio Monteagudo, Jose A Piqueras, Tatiana Cobo, Joan Maymó, Carmen Barbadillo, Soledad Ojeda, Jaime Calvo Alen, Antonio Fernandez Nebro, Isabel Rodríguez, Pilar Font, Martina Steiner, Eugenio Chamizo Carmona, Beatriz González Álvarez, Santiago Munoz, Joan M Nolla, Fernando Sánchez-Alonso, Julio Sanchez, Raul Menor Almagro, Ana Pérez Gómez, Monica Ibañez, Elena Heras-Recuero, Trinidad Pérez Sandoval, Miren Uriarte-Ecenarro, Angela Pecondón, Hye Sang Park, Jessica Polo y La Borda, Zulema Plaza, Carmen García Gómez, Ivan Ferraz-Amaro, Jesús Tomás Sanchez-Costa, Olga Carmen Sánchez-González, Ana Isabel Turrión-Nieves, Ana Perez-Alcalá, José L FernándezSueiro, José A Pinto-Tasende, Eugenia Gonzálezde Rábago, María J González-Fernández, Ramón Huguet Codina, Beatriz Yoldi, Mercedes Ramentol, Gabriela Ávila, Cayetano Alegre, Fernando Gamero, José García Torón, María P Moreno-Gil, Antonio Juan-Mas, Pilar Espiño, Inmaculada Ros, Horacio Berman, Oscar Fontseré Patón, Benjamín Fernández Gutiérrez, José M Pina-Salvador, María D Fábregas, Montserrat Romera, Jesús A García-Vadillo, Rosario García de Vicuña, María A Belmonte, María V Irigoyen, Olga Martínez González, Rebeca Belmonte Gómez, Pastora Granados Bautista, Azucena Hernández Sanz, José Santos Rey, Carmen O Sánchez-González, Javier Bachiller, Antonio Zea, Francisco J Manero, Chesús Beltrán Audera, Marta Medrano, Jesús Babío Herráez, Javier del Pino, Ruth López González, María Enriqueta Peiró, José M Senabre, José C Rosas, Isabel Rotés, Estefanía Moreno, Javier Calvo, Amalia Rueda, Pilar Morales, Ana Nieto, Ana Ruibal Escribano, Sergio Ros Expósito, Ginés Sánchez Nievas, Enrique Júdez Navarro, Manuela Sianes Fernández, Silvia Martínez Pardo, Manel Pujol, Alberto Cantabrana, Esmeralda Delgado, Sergio Rodríguez Montero, Javier Rivera Redondo, Teresa González Hernández, Francisco J González-Polo, José M Moreno, Emilio Giner Serret, Laura Cebrián Méndez, María Teresa Navío, Teresa Pedraz Penalva, Encarnación Pagán, Pablo Mesadel Castillo, Ana Cruz, Ana Turrión, Desireé Ruíz, Antonio López Meseguer, Manuel J Moreno, Luis F Linares, Mercedes Morcillo, María L González-Gómez, José M Aramburu, Natalia A Rivera, Olaia Fernández Berrizbeitia, Manel Riera, Yolanda María León, Miriam Amirall, Jordi Fiter, Julia Fernández Melón, Luis Espadaler, Joaquín Belzunegui, Inmaculada Bañegil, César Díaz, Ramón Valls, María Bonet, Eva Revuelta Evrard, Javier R Godo, and José A González-Fernández

Subjects
Medicine
Abstract

Objective To assess the predictive value of four cardiovascular (CV) risk algorithms for identifying high-risk psoriatic arthritis (PsA) patients.Methods Evaluation of patients with PsA enrolled in the Spanish prospective project CARdiovascular in RheuMAtology. Baseline data of 669 PsA patients with no history of CV events at the baseline visit, who were followed in rheumatology outpatient clinics at tertiary centres for 7.5 years, were retrospectively analysed to test the performance of the Systematic Coronary Risk Assessment (SCORE), the modified version (mSCORE) European Alliance of Rheumatology Associations (EULAR) 2015/2016, the SCORE2 algorithm (the updated and improved version of SCORE) and the QRESEARCH risk estimator version 3 (QRISK3).Results Over 4790 years of follow-up, there were 34 CV events, resulting in a linearised rate of 7.10 per 1000 person-years (95% CI 4.92 to 9.92). The four CV risk scales showed strong correlations and all showed significant associations with CV events (p

Published
2024
Full Text
View/download PDF

2. P129 Does the perspective of SLE patients match the expert opinion and definitions of remission and low disease activity state? Prospective analysis of 500 patients from a Spanish multicenter cohort

Author

María Galindo, Luís Inês, Francisco Rubiño, Iñigo Rua Figueroa, Eva Tomero Muriel, Coral Mouriño Rodriguez, Esther Uriarte Isacelaya, Jose Maria Pego Reigosa, Irene Altabás González, Esther Rodriguez Almaraz, Inigo Hernandez Rodriguez, Raul Menor Almagro, Tarek Salman Montes, Irene Carrion Barbera, and Norman Jimenez

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2024
Full Text
View/download PDF

3. O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort

Author

Íñigo Rúa-Figueroa, José A Gómez-Puerta, Javier Narváez, Eva Tomero, Clara Moriano, Elvira Díez Álvarez, Consuelo Ramos Giráldez, Maria Angeles Blazquez Cañamero, Maria Galindo Izquierdo, Jaime Calvo Alen, Jose Maria Pego Reigosa, Irene Altabás González, Beatriz Frade-Sosa, Margarida Vasques Rocha, Andrea Hernández-Martín, Paola Vidal-Montal, Eleonora Penzo, Marta de la Rubia Navarro, José Andrés Román Ivorra, Raul Menor Almagro, Tarek Salman Montes, Norman Jiménez Otero, Judit Font Urgelles, Ivette Casafont Sole, María Jesús García Villanueva, Carlos Marras Fernández, María Piqueras García, Julia Martínez Barrio, Marina Sánchez Lucas, Josefina Cortés Hernández, Myriam Gandía Martínez, Carmen Trapero Pérez, and Alejandro Muñoz Jiménez

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2024
Full Text
View/download PDF

4. P147 Is belimumab dose optimization possible in patients with systemic lupus erythematosus? Analysis of this therapeutic strategy in a large multicenter cohort of patients from Spanish rheumatology departments

Author

Íñigo Rúa-Figueroa, Jose Maria Pego-Reigosa, Javier Narváez, Ivette Casafont-Solé, Eva Tomero, Clara Moriano, Elvira Díez Álvarez, María Jesús García-Villanueva, Consuelo Ramos Giráldez, Sandra Garrote, Maria Galindo Izquierdo, Jaime Calvo Alen, Beatriz Frade-Sosa, Irene Altabás-González, Andrea Hernández-Martín, Paola Vidal-Montal, Eleonora Penzo, Marta de la Rubia Navarro, José Andrés Román Ivorra, Raul Menor Almagro, Tarek Salman Montes, Norman Jimenez, Judit Font Urgelles, Carlos Marras Fernández, María Piqueras García, Julia Martínez Barrio, Marina Sánchez Lucas, Josefina Cortés Hernández, Myriam Gandía Martínez, Carmen Trapero Pérez, Alejandro Muñoz Jiménez, Juan Ramón de Dios, and Jos A Gómez-Puerta

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2024
Full Text
View/download PDF

5. Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

Author

Carlos Montilla, Paloma Vela, Íñigo Rúa-Figueroa, José M Pego-Reigosa, Karen Roberts, Javier Narváez, Raúl Menor-Almagro, Alejandro Olivé, María Galindo, Antonio Fernández-Nebro, Eva Tomero, Julia Martínez-Barrio, Javier Manero, Gema Bonilla, Elena Aurrecoechea, María Jesús García-Villanueva, Eva Salgado, Mercedes Freire-González, Vicenç Torrente-Segarra, Jaime Calvo Alen, Victor Del Campo Perez, Gregorio Santos Soler, Cristina Bohorquez, Irene Altabás-González, Norman Jimenez, Coral Mouriño, Nuria Lozano-Rivas, Ana Paula Cacheda, Esther Uriarte Itzazelaia, Víctor Martínez Taboada, José Ángel Hernández-Beriain, Oihane Ibarguengoitia-Barrena, Claudia Moriano-Morales, and Concepción Fito Manteca

Subjects
Immunologic diseases. Allergy, RC581-607
Abstract

Objective To assess organ damage, with emphasis on the cardiovascular system, over the different stages of the disease in a large SLE cohort.Methods Multicentre, longitudinal study of a cohort of 4219 patients with SLE enrolled in the Spanish Society of Rheumatology Lupus Registry. Organ damage was ascertained using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). We longitudinally analysed SDI (globally and for each domain) over time only in the 1274 patients whose dates of damage events had been recorded.Results During the first year after diagnosis of SLE, 20% of the 1274 patients presented with new damage manifestations. At years 2 and 3, new damage was recorded in 11% and 9% of patients. The annual percentage of patients with new damage after year 5 decreased to 5%. In the first year with the disease, most damage was accumulated in the musculoskeletal, neuropsychiatric and renal systems; in later stages, most damage was in the musculoskeletal, ocular and cardiovascular systems. Considering ‘cerebrovascular accident’ and ‘claudication for 6 months’ as cardiovascular items, the cardiovascular system was the second most affected system during the early stages of SLE, with 19% of the patients who presented with damage affected at first year after diagnosis. During the late stages, 20–25% of the patients presenting with new damage did so in this modified cardiovascular domain of the SDI.Conclusions New damage occurs mainly during the first year following diagnosis of SLE. Cardiovascular damage is relevant in both the early and the late stages of the disease. Strategies to prevent cardiovascular damage should be implemented early after diagnosis of SLE.

Published
2024
Full Text
View/download PDF

6. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

Author

Loreto Carmona, Carlos Montilla, Ricardo Blanco, Ana Pérez, Íñigo Rúa-Figueroa, Celia Erausquin, Beatriz Tejera Segura, Javier Narváez, Irene Carrión-Barberà, Jorge Juan Fragío Gil, Raúl Menor-Almagro, Antonio Fernández-Nebro, Eva Tomero, Esther Ruiz-Lucea, Julia Martínez-Barrio, Gema Bonilla, Elena Aurrecoechea, María Jesús García-Villanueva, Eva Salgado, Mercedes Freire-González, Jaime Calvo Alen, Tatiana Cobo, María Galindo Izquierdo, Mónica Ibáñez-Barcelo, Loreto Horcada, Lorena Expósito, Joan M Nolla, Alejandro Muñoz-Jiménez, Jose L Andreu, Clara Sanguesa, Nuria Lozano-Rivas, Marta Arévalo, Carlota Iniguez, M Jesus García de Yébenes, Esther Uriarte Itzazelaia, José Carlos Rosas Gómez de Salazar, Silvia Gómez-Sabater, Claudia Moriano Morales, Vicente Torrente Segarra, Javier Nóvoa Medina, Angela Pecondón, Francisco J Toyos, Jose Oller, and J M Pego-Reigosa

Subjects
Immunologic diseases. Allergy, RC581-607
Abstract

Objective To develop an improved score for prediction of severe infection in patients with systemic lupus erythematosus (SLE), namely, the SLE Severe Infection Score-Revised (SLESIS-R) and to validate it in a large multicentre lupus cohort.Methods We used data from the prospective phase of RELESSER (RELESSER-PROS), the SLE register of the Spanish Society of Rheumatology. A multivariable logistic model was constructed taking into account the variables already forming the SLESIS score, plus all other potential predictors identified in a literature review. Performance was analysed using the C-statistic and the area under the receiver operating characteristic curve (AUROC). Internal validation was carried out using a 100-sample bootstrapping procedure. ORs were transformed into score items, and the AUROC was used to determine performance.Results A total of 1459 patients who had completed 1 year of follow-up were included in the development cohort (mean age, 49±13 years; 90% women). Twenty-five (1.7%) had experienced ≥1 severe infection. According to the adjusted multivariate model, severe infection could be predicted from four variables: age (years) ≥60, previous SLE-related hospitalisation, previous serious infection and glucocorticoid dose. A score was built from the best model, taking values from 0 to 17. The AUROC was 0.861 (0.777–0.946). The cut-off chosen was ≥6, which exhibited an accuracy of 85.9% and a positive likelihood ratio of 5.48.Conclusions SLESIS-R is an accurate and feasible instrument for predicting infections in patients with SLE. SLESIS-R could help to make informed decisions on the use of immunosuppressants and the implementation of preventive measures.

Published
2024
Full Text
View/download PDF

7. O17 SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus, developed from RELESSER prospective database cohort

Author

Loreto Carmona, Ricardo Blanco, Íñigo Rúa-Figueroa, Celia Erausquin, María Jesus García de Yébenes, José M Pego-Reigosa, Javier Narváez, Raúl Menor-Almagro, Jaime Calvo-Alén, Antonio Fernández-Nebro, Eva Tomero, Mercedes Freire, Esther Ruiz-Lucea, Julia Martínez-Barrio, María Galindo-Izquierdo, Clara Moriano, Elena Aurrecoechea, Jose Luis Andreu, Jose Rosas, Tatiana Cobo, Ángela Pecondón-Español, Loreto Horcada, Esther Uriarte Isacelaya, Lorena Expósito, Alejandro Muñoz-Jiménez, Irene Carrion Barbera, Beatriz García-Tejera, Clara Sanguesa, Silvia Gómez Sabater, Vicenç Torrente Segarra, Ana Pérez Gómez, Francisco J Nóvoa, Eva Salgado Pérez, Nuria Lozano-Rivas, Carlos Montilla-Morales, Marta Arévalo, Carlota Iniguez, Maria J García Villanueva, Monica Ibañez, Gema Bonilla Hernán, Jorge Fragío, Francisco Javier Toyos, and José Eloy Oller

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2024
Full Text
View/download PDF

8. LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort

Author

Íñigo Rúa-Figueroa, Jose Maria Pego-Reigosa, José A Gómez-Puerta, Javier Narváez, Ivette Casafont-Solé, José Andrés Román-Ivorra, Raúl Menor-Almagro, Jaime Calvo-Alén, Eva Tomero, Julia Martínez-Barrio, María Galindo-Izquierdo, Clara Moriano, Josefina Cortés-Hernández, María Jesús García-Villanueva, Elvira Díez-Álvarez, Irene Altabás-González, Coral Mouriño-Rodriguez, Norman Jiménez-Otero, Andrea Hernández-Martín, Judit Font-Urgelles, Marta De La Rubia-Navarro, Tarek Salman-Montes, Paola Vidal-Montal, Sandra Garrote-Corral, María Ángeles Blázquez-Cañamero, Carlos Marras-Fernández, María Piqueras-García, Marina Sánchez-Lucas, Eleonora Penzo, Juan Ramón De Dios Jiménez De Aberásturi, Belén Álvarez-Rodríguez, Margarida Vasques-Rocha, Myriam Gandía-Martínez, Consuelo Ramos-Giráldez, Carmen Trapero-Pérez, and Alejandro Muñoz-Jiménez

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results